 |
Alpha-9 Oncology
Last updated: October 24, 2024
Founder David Perrin
Canada | Funding: $210.5M (+)
Website: https://www.alpha9tx.com/
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Website: https://www.alpha9tx.com/
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
